Demonstration patient consultation: COPD review – ICST

Demonstration patient consultation: COPD review

Consultation demonstrated by Dave Edwards, Respiratory Pharmacist, South Pembrokeshire Cluster.

The following steps are recommended for a COPD consultation:

Confirm Diagnosis

  • evidence of post-bronchodilator spirometry FEV1/FVC ratio less than LLN
  • blood eosinophil level and CXR is also recommended

Record the relevant information

  • smoking status
  • MRC score
  • CAT score
  • SpO2
  • Number of exacerbations in past 12 months
  • BMI

Optimise therapy

Non-pharmacological:

  • Smoking cessation referral
  • Pneumonia/flu/covid vaccinations
  • Pulmonary rehabilitation referral (MRC3 and above)
  • Inhaler technique check

Pharmacological:

Phenotype patient according to All Wales COPD Guidelines, and prescribe inhalers accordingly:

  • Phenotype 1 – COPD with mainly breathlessness
  • Phenotype 2 – COPD with exacerbations (+/- breathlessness)
  • Phenotype 3 – COPD with asthma overlap

Optimal pharmacological treatment will depend on the patient’s phenotype.

Demonstration patient consultation: COPD review

Consultation demonstrated by Dave Edwards, Respiratory Pharmacist, South Pembrokeshire Cluster.

The following steps are recommended for a COPD consultation:

Confirm Diagnosis

  • evidence of post-bronchodilator spirometry FEV1/FVC ratio less than LLN
  • blood eosinophil level and CXR is also recommended

Record the relevant information

  • smoking status
  • MRC score
  • CAT score
  • SpO2
  • Number of exacerbations in past 12 months
  • BMI

Optimise therapy

Non-pharmacological:

  • Smoking cessation referral
  • Pneumonia/flu/covid vaccinations
  • Pulmonary rehabilitation referral (MRC3 and above)
  • Inhaler technique check

Pharmacological:

Phenotype patient according to All Wales COPD Guidelines, and prescribe inhalers accordingly:

  • Phenotype 1 – COPD with mainly breathlessness
  • Phenotype 2 – COPD with exacerbations (+/- breathlessness)
  • Phenotype 3 – COPD with asthma overlap

Optimal pharmacological treatment will depend on the patient’s phenotype.

Demonstration patient consultation: Asthma review

Mark as Understood
© Institute of Clinical Science and Technology (ICST) 2020 Support: support@icst.org.uk